Psychosocial influences on HIV-1 disease progression: Neural, endocrine, and virologic mechanisms

被引:63
作者
Cole, Steve W. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Sch Med,AIDS Inst, Dept Med,Jonsson Comprehens Canc Ctr, Div Hematol Oncol,Norman Cousins Ctr, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA
来源
PSYCHOSOMATIC MEDICINE | 2008年 / 70卷 / 05期
关键词
HIV-1; disease progression; sympathetic nervous system; HPA axis; neuroendocrine; catecholamine; norepinephrine; cortisol;
D O I
10.1097/PSY.0b013e3181773bbd
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
This review surveys empirical research pertinent to the hypothesis that activity of the hypothalamus-pituitary-adrenal (HPA) axis and/or the sympathetic nervous system (SNS) might mediate biobehavioral influences on HIV-1 pathogenesis and disease progression. Data are considered based on causal effects of neuroeffector molecules on HIV- I replication, prospective relationships between neural/endocrine parameters and HIV-relevant biological or clinical markers, and correlational data consistent with in vivo neural/endocrine mediation in human or animal studies. Results show that HPA and SNS effector molecules can enhance HIV-1 replication in cellular models via effects on viral infectivity, viral gene expression, and the innate immune response to infection. Animal models and human clinical studies both provide evidence consistent with SNS regulation of viral replication, but data on HPA mediation are less clear. Regulation of leukocyte biology by neuroeffector molecules provides a plausible biological mechanism by which psychosocial factors might influence HIV-1 pathogenesis, even in the era of effective antiretroviral therapy. As such, neural and endocrine parameters might provide useful biomarkers for gauging the promise of behavioral interventions and suggest novel adjunctive strategies for controlling HIV- I disease progression.
引用
收藏
页码:562 / 568
页数:7
相关论文
共 77 条
[1]
Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection [J].
Andrieu, Jean-Marie ;
Lu, Wei .
BMC MEDICINE, 2004, 2 (1)
[2]
Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men [J].
Antoni, MH ;
Cruess, S ;
Cruess, DG ;
Kumar, M ;
Lutgendorf, S ;
Ironson, G ;
Dettmer, E ;
Williams, J ;
Klimas, N ;
Fletcher, MA ;
Schneiderman, N .
ANNALS OF BEHAVIORAL MEDICINE, 2000, 22 (01) :29-37
[3]
HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro [J].
Ayyavoo, V ;
Mahalingam, S ;
Rafaeli, Y ;
Kudchodkar, S ;
Chang, D ;
Nagashunmugam, T ;
Williams, WV ;
Weiner, DB .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (01) :93-99
[4]
THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS [J].
BARON, RM ;
KENNY, DA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) :1173-1182
[5]
BELLINGER DL, 2001, PSYCHONEUROIMMUNOLOG
[6]
Social stress results in altered glucocorticoid regulation and shorter survival in simian acquired immune deficiency syndrome [J].
Capitanio, JP ;
Mendoza, SP ;
Lerche, NW ;
Mason, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4714-4719
[7]
CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells [J].
Caulfield, J ;
Fernandez, M ;
Snetkov, V ;
Lee, T ;
Hawrylowicz, C .
IMMUNOLOGY, 2002, 105 (02) :155-162
[8]
Serum cortisol and DHEA concentrations during HIV infection [J].
Christeff, N ;
Gherbi, N ;
Mammes, O ;
Dalle, MT ;
Gharakhanian, S ;
Lortholary, O ;
Melchior, JC ;
Nunez, EA .
PSYCHONEUROENDOCRINOLOGY, 1997, 22 :S11-S18
[9]
Cole S., 2001, Psychoneuroimmunology, V2, P583
[10]
Social identity and physical health: Accelerated HIV progression in rejection-sensitive gay men [J].
Cole, SW ;
Kemeny, ME ;
Taylor, SE .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1997, 72 (02) :320-335